Pharmacology and Biological Efficacy of a Recombinant, Humanized, Single-Chain Antibody C5 Complement Inhibitor in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardiopulmonary Bypass

Circulation - United States
doi 10.1161/01.cir.100.25.2499
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Coronary Artery Bypass Graft Surgery

2007English

On Pump Coronary Artery Bypass Graft Surgery Versus Off Pump Coronary Artery Bypass Graft Surgery: A Review

Global journal of health science
Medicine
2014English

Pain Management With Non-Pharmacological Methods in Patients Undergoing Coronary Artery Bypass Graft Surgery: Review

Turkiye Klinikleri Journal of Nursing
2016English

Is There a Role for Diagonal Coronary Artery Stenting in Patients Undergoing Robotic Coronary Artery Bypass Graft Surgery?

Journal of Clinical Medicine Research
2018English

Expected and Observed Mortality in Patients Undergoing Coronary Artery Bypass Surgery

Turkiye Klinikleri Journal of Medical Sciences
Medicine
2015English

Neurological Complications of Coronary Artery Bypass Graft Surgery.

BMJ
1986English

Neurological Complications of Coronary Artery Bypass Graft Surgery.

BMJ
1986English

Role of Trimetazidine in Coronary Artery Bypass Graft Surgery

World Journal of Cardiovascular Surgery
2017English

Association Between Incidence of Atrial Fibrillation and Duration of Cardiopulmonary Bypass in Coronary Artery Bypass Graft Surgery (CABG): A Cohort Study

Electronic Physician
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy